Coya Therapeutics (COYA) Revenue & Revenue Breakdown
Coya Therapeutics Revenue Highlights
Latest Revenue (Y)
$3.55B
Latest Revenue (Q)
$3.56B
Coya Therapeutics Revenue by Period
Coya Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $3.55B | 59112.58% |
| 2023-12-31 | $6.00M | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
Coya Therapeutics generated $3.55B in revenue during NA 2024, up 59112.58% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Coya Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $3.56B | 2178326.32% |
| 2025-06-30 | $163.62K | -36.55% |
| 2025-03-31 | $257.88K | 13111.27% |
| 2024-12-31 | $1.95K | 100.00% |
| 2024-09-30 | - | -100.00% |
| 2024-06-30 | $3.43M | 2600.51% |
| 2024-03-31 | $126.84K | -97.89% |
| 2023-12-31 | $6.00M | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | - |
Coya Therapeutics generated $3.56B in revenue during Q3 2025, up 2178326.32% compared to the previous quarter, and up 104057.58% compared to the same period a year ago.
Coya Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COYA | Coya Therapeutics | $3.55B | $3.56B |
| MGNX | MacroGenics | $149.96M | $22.24M |
| ZNTL | Zentalis Pharmaceuticals | $67.42M | - |
| WHWK | Whitehawk Therapeutics | $25.98M | $7.24M |
| STTK | Shattuck Labs | $5.72M | - |
| ORMP | Oramed Pharmaceuticals | $1.34M | - |
| OVID | Ovid Therapeutics | $566.00K | $132.00K |
| CLNN | Clene | $342.00K | $15.00K |
| CNTX | Context Therapeutics | - | - |
| IMMX | Immix Biopharma | - | - |
| PLRX | Pliant Therapeutics | - | - |